Prana Biotechnology files $50 million shelf covering stock, preferreds

By Devika Patel

Knoxville, Tenn., May 17 - Prana Biotechnology Ltd. filed a $50 million shelf registration in an F-3 filing with the Securities and Exchange Commission.

The registration covers ordinary shares represented by American Depositary Shares, warrants and debt securities.

The debt may be structured as convertibles.

Proceeds will be used for ongoing and future research programs and working capital purposes.

Prana is a Melbourne, Australia-based biopharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.